Reporter April 3 2015

Micelle “packets” deliver cancer drugs

Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells.

New player in heart cell growth

Vanderbilt researchers have identified a new protein involved in heart cell growth, which could improve understanding of pathologic cardiac hypertrophy.

Cancer signaling pathway blocker

Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer.

Gene variant, environment can boost RSV severity

A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.

VUMC’s Denny named to NIH precision medicine group

Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, will help guide planning for the precision medicine initiative announced by President Obama in his January State of the Union Address.

NCI’s national report shows cancer deaths on decline in U.S.

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.

1 2